COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 126: Articles 1251-1260  | Next

Immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines for SARS-CoV-2
Singh, O. N., Berry, U., Joshi, G., Asuru, T. R., Chandrasekar, K., Narayanan, S., Srivastava, P., Tiwari, M., Chattopadhyay, S., Mehdi, F., Panda, B. N., Nayak, D., Mani, S., Shrivastava, T., Batra, G., Ranjith-Kumar, C., Guchhait, P., Surjit, M.
10.1101/2024.08.23.609366 — Posted: 2024-08-27
Measuring Disparities in the Impact of COVID-19 on Pediatric Mental Health in Primary Care Settings
Rogers, C. E., Boguszewski, K. E., Gummadi, A. K. S., Conaway, M. R., Shaffer, L. A., Mathieu, I. P.
10.1101/2024.08.26.24312603 — Posted: 2024-08-26
Extensive exploration of structure activity relationships for the SARS-CoV-2 macrodomain from shape-based fragment merging and active learning
Correy, G. J., Rachman, M. M., Togo, T., Gahbauer, S., Doruk, Y. U., Stevens, M. G. V., Jaishankar, P., Kelley, B., Goldman, B., Schmidt, M., Kramer, T., Ashworth, A., Riley, P., Shoichet, B. K., Renslo, A. R., Walters, W. P., Fraser, J. S.
10.1101/2024.08.25.609621 — Posted: 2024-08-26
Molecular basis of pathogenicity of the recently emerged FCoV-23 coronavirus
Tortorici, M. A., Choi, A., Gibson, C., Lee, J., Brown, J. T., Stewart, C., Joshi, A., Harari, S., Willoughby, I., Treichel, C., Leif, E., Bloom, J. D., King, N. P., Tait-Burkard, C., Whittaker, G. R., Veesler, D.
10.1101/2024.08.25.607996 — Posted: 2024-08-26
Possible impact of national responses to the COVID pandemic on medal tallies at the Paris 2024 Olympics
Orchard, J. W., Luies, N., Buckley, R. J., Castricum, A.
10.1101/2024.08.23.24312521 — Posted: 2024-08-26
Does hospital overload increase the risk of death when infected by SARS-CoV-2?
Glemain, B., Assaad, C., Ghosn, W., Moulaire, P., de Lamballerie, X., Zins, M., Severi, G., Touvier, M., Deleuze, J.-F., SAPRIS-SERO Study Group, , Lapidus, N., Carrat, F.
10.1101/2024.08.26.24312569 — Posted: 2024-08-26
A counterfactual analysis quantifying the COVID-19 vaccination impact in Sweden
Bergstrom, F., Gunther, F., Britton, T.
10.1101/2024.08.22.24312361 — Posted: 2024-08-23
Unraveling the impact of COVID-19 on urban mobility: A Causal Machine Learning Analysis of Beijing's Subway System
Zou, L., Chen, Y., Guo, R., Wang, P., He, Y., Chen, S., Wang, Z., Zhu, J.
10.1101/2024.08.22.24312324 — Posted: 2024-08-23
Post-discharge health-related quality of life, cognitive function, disability, risk of post-traumatic stress disorder, and depression amongst the survivors of venovenous extracorporeal membrane oxygenation (VV-ECMO) during the COVID-19 pandemic: a nested cohort study protocol
Ursu, E., Mikolic, A., Thiara, S., Silverberg, N. D., Foster, D., Panenka, W., Parag, N., Sekhon, M. S., Griesdale, D. E. G.
10.1101/2024.08.22.24312450 — Posted: 2024-08-23
Bronchoalveolar Lavage Single-Cell Transcriptomics Identifies Immune Cells Driving COVID-19 Severity in Patients
Asaba, C. N., Bitazar, R., Labonte, P. N., Bukong, T. N.
10.1101/2024.08.22.609137 — Posted: 2024-08-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).